TB Alliance Spins-out Non-TB Assets to TenNor Therapeutics
NEW YORK, NY – TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) […]
NEW YORK, NY – TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) […]
30 October 2013 (PARIS, FRANCE): In an effort to develop and deliver treatments for children with tuberculosis (TB)—answering a critical
New York, USA: TB Alliance has received a grant from the United Kingdom’s Department for International Development (DFID) to support
New York, USA: The Global Alliance for TB Drug Development (TB Alliance) has received a grant from the Australian Agency
The Global Health Innovative Technology Fund (GHIT Fund), a new public-private partnership that’s bringing Japanese research and development (R&D) to
TB Alliance, a not-for-profit organization with the mission of developing better, faster-acting, and affordable TB treatments, announces the election of
As Product Development Partnerships (PDPs) dedicated to the discovery, development and delivery of new global health tools, we applaud the
TB Alliance, an international non-profit organization which develops better, faster-acting, and affordable TB drugs, has announced that it has granted
Over the past year, the pursuit of new TB drugs has seen incredible progress. Positive results of first regimen trial
In spite of an estimated 500,000 new annual cases of children with tuberculosis (TB), there are no appropriate medicines for